Skip to content

Clinical trials

Phase 3 Myocardial Infarction trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 3 Country / region: Australia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20061
20071
20081
20091
20101
20111
20134
20141
20171
20191
20201
20212
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Recruiting3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AstraZeneca2
Pfizer2
Sanofi2
Amgen1
Bayer1
Boehringer Ingelheim1
Cogentus Pharmaceuticals1
GlaxoSmithKline1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction22
Stroke13
Cardiovascular Diseases10
Acute Coronary Syndrome6
Coronary Artery Disease5
Heart Diseases3
Hyperlipidemias3
ST Elevation Myocardial Infarction3
Angina, Unstable2
Diabetes Mellitus2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.